Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial

Objective: To compare the effect of glucose-lowering drugs on peripheral nerve and kidney function in prediabetes. Methods: Multicenter, randomized, placebo-controlled trial in 658 adults with prediabetes treated for 1 year with metformin, linagliptin, their combination or placebo. Endpoints are sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabriel, Rafael, Boukichou-Abdelkader, Nisa, Gilis-Januszewska, Aleksandra, Makrilakis, Konstantinos, Gómez-Huelgas, Ricardo, Kamenov, Zdravko, Paulweber, Bernhard, Satman, Ilhan, Djordjevic, Predrag, Alkandari, Abdullah, Mitrakou, Asimina, Lalic, Nebojsa, Egido, Jesús, Más-Fontao, Sebastián, Calvet, Jean Henri, Pastor, José Carlos, Lindström, Jaana, Lind, Marcus, Acosta, Tania, Silva, Luis, Tuomilehto, Jaakko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004435/
https://www.ncbi.nlm.nih.gov/pubmed/36902821
http://dx.doi.org/10.3390/jcm12052035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004435/
https://www.ncbi.nlm.nih.gov/pubmed/36902821
http://dx.doi.org/10.3390/jcm12052035

Ejemplares similares